Romeo QuijanoBunkerd KongyingyoesAmnuay ThithapandhaMahidol University2018-06-012018-06-011979-01-01Proceedings of the Society for Experimental Biology and Medicine. Vol.162, No.3 (1979), 442-44415353699003797272-s2.0-0018628585https://repository.li.mahidol.ac.th/handle/20.500.14594/13159The effects of three highly bound acids, viz salicylic acid, indomethacin, and dicloxacillin, on the binding of phenylbutazone to human plasma proteins were studied by equilibrium dialysis. Salicylic acid was found to displace phenylbutazone from its binding sites to a degree which might be clinically significant. Indomethacin caused a slight decrease in the percentage binding of phenylbutazone which is not likely to be of clinical importance. Dicloxacillin, however, did not appear to affect the plasma protein binding of phenylbutazone suggesting that the two drugs could be bound at mutually noninteracting sites in the protein molecule. © 1979, SAGE Publications. All rights reserved.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyPhenylbutazone Plasma Binding: Effects of Salicylic Acid, Indomethacin, and DicloxacillinArticleSCOPUS10.3181/00379727-162-40700